Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

MIRA GENETIX

NPI: 1912787144 · FAIRFAX, VA 22033 · Clinical Medical Laboratory · NPI assigned 10/04/2023

$12K
Total Medicaid Paid
3,830
Total Claims
3,250
Beneficiaries
31
Codes Billed
2024-02
First Month
2024-12
Last Month

Provider Details

Authorized OfficialRAY, MICHAEL (COO)
NPI Enumeration Date10/04/2023

Related Entities

Other providers sharing the same authorized official: RAY, MICHAEL

ProviderCityStateTotal Paid
HELPING HAND ASSOCIATION SALT LAKE CITY UT $18.42M
SEVENTH STREET TREATMENT CENTER SALT LAKE CITY UT $7.40M
MIDWEST MOBILE CARE INC FRANKLIN IN $795K
M&K HEALTH CARE CLINICS RIO RANCHO NM $122K
WEST LIBERTY CARE CENTER INC WEST LIBERTY OH $259.39

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2024 3,830 $12K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 468 376 $9K
87481 357 307 $1K
87500 399 320 $546.63
87641 359 325 $441.62
87653 381 324 $437.58
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 123 76 $186.42
87640 238 198 $150.50
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 29 25 $140.37
87109 194 160 $49.80
87186 73 66 $34.60
87086 Culture, bacterial; quantitative colony count, urine 54 50 $32.28
87088 49 45 $29.12
81001 193 165 $15.85
0311U 93 82 $3.24
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 79 55 $0.00
82607 13 13 $0.00
83036 Hemoglobin; glycosylated (A1C) 34 33 $0.00
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 91 82 $0.00
85025 Blood count; complete (CBC), automated, and automated differential WBC count 88 79 $0.00
84443 Thyroid stimulating hormone (TSH) 58 53 $0.00
0068U 33 30 $0.00
80048 Basic metabolic panel (calcium, ionized) 92 84 $0.00
82746 13 12 $0.00
87797 33 30 $0.00
87540 14 13 $0.00
84439 41 39 $0.00
80076 89 80 $0.00
80061 Lipid panel 84 75 $0.00
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 14 13 $0.00
87799 30 27 $0.00
87580 14 13 $0.00